Skip to main content

Table 2 Means (standard deviations) of scales for patients and their proxies at baseline, follow-up, and change in score (follow-up – baseline), and intra-class correlation coefficients

From: Patient-proxy agreement on change in acute stroke patient-reported outcome measures: a prospective study

Domain

Visit

Self-Reported

Mean (SD)

Proxy-Reported

Mean (SD)

Difference

(Proxy – Self-Report)

Mean (SD)

ICC (95% CI)

Cognitive Function, n = 40

Baseline

46.9 (9.9)

43.8 (9.5)

− 2.6 (8.1)*

0.63 (0.44, 0.76)

Follow-up

47.4 (9.2)

43.8 (10.1)

−3.5 (7.4)*

0.67 (0.46, 0.80)

Change

0.8 (8.7)

0.0 (8.1)

−0.8 (10.1)

0.29 (0.04, 0.51)

Physical Function, n = 41

Baseline

36.0 (9.8)

36.6 (10.3)

0.6 (8.3)

0.67 (0.50, 0.79)

Follow-up

38.6 (11.7)

37.4 (10.7)

−1.2 (6.4)

0.84 (0.74, 0.90)

Change

2.7 (5.2)ƚ

0.8 (10.1)

−1.8 (8.6)

0.42 (0.18, 0.61)

Global Mental Health, n = 41

Baseline

46.2 (8.8)

46.8 (9.0)

0.6 (9.4)

0.45 (0.22, 0.64)

Follow-up

48.1 (9.0)

44.2 (10.1)

−4.0 (8.0)*

0.60 (0.37, 0.75)

Change

1.9 (6.6)

−2.6 (6.6)ƚ

−4.6 (8.7)*

0.11 (− 0.10, 0.32)

Global Physical Health, n = 41

Baseline

41.4 (7.6)

41.6 (7.7)

0.2 (7.8)

0.48 (0.26, 0.66)

Follow-up

44.5 (8.8)

42.9 (8.6)

−1.7 (5.4)

0.80 (0.68, 0.88)

Change

3.1 (7.3)ƚ

1.3 (8.0)

−1.8 (7.4)

0.53 (0.32, 0.69)

Social Role Satisfaction, n = 41

Baseline

40.8 (9.2)

42.5 (9.0)

1.7 (9.7)

0.42 (0.19, 0.61)

Follow-up

44.9 (10.0)

43.3 (11.5)

−1.7 (10.7)

0.51 (0.29, 0.68)

Change

4.1 (5.9)ƚ

0.7 (10.2)

−3.4 (10.3)*

0.21 (− 0.03, 0.44)

Anxietyǂ, n = 41

Baseline

51.4 (7.4)

54.5 (9.2)

3.1 (10.0)

0.27 (0.03, 0.48)

Follow-up

47.8 (8.9)

52.1 (8.8)

4.3 (9.1)*

0.42 (0.19, 0.62)

Change

−3.6 (9.2)ƚ

−2.4 (10.6)

1.2 (10.6)

0.43 (0.20, 0.62)

Depressionǂ, n = 40

Baseline

52.8 (8.1)

54.7 (9.2)

1.9 (11.7)

0.09 (− 0.17, 0.34)

Follow-up

51.4 (8.8)

53.0 (9.0)

1.8 (8.1)

0.58 (0.38, 0.73)

Change

−1.1 (8.1)

−1.7 (10.1)

− 0.5 (12.7)

0.06 (− 0.20, 0.31)

Fatigueǂ, n = 41

Baseline

57.6 (7.6)

57.9 (7.5)

0.3 (9.3)

0.26 (0.00, 0.48)

Follow-up

53.0 (9.3)

56.9 (9.7)

3.8 (9.1)*

0.51 (0.28, 0.68)

Change

−4.6 (7.1)ƚ

−1.0 (9.8)

3.6 (10.7)*

0.20 (− 0.04, 0.43)

Pain Interferenceǂ, n = 41

Baseline

52.3 (10.0)

51.5 (9.6)

−0.7 (8.8)

0.60 (0.41, 0.74)

Follow-up

50.9 (10.5)

50.6 (9.6)

−0.3 (7.5)

0.73 (0.58, 0.83)

Change

−1.4 (8.4)

−0.9 (9.6)

0.5 (9.3)

0.47 (0.25, 0.65)

Sleep Disturbanceǂ, n = 40

Baseline

51.8 (8.4)

51.3 (10.5)

−0.5 (8.1)

0.65 (0.47, 0.78)

Follow-up

50.2 (9.7)

49.4 (10.3)

−0.3 (9.7)

0.54 (0.33, 0.70)

Change

−2.0 (10.7)

−1.9 (9.1)

0.1 (10.0)

0.50 (0.28, 0.67)

  1. *p < 0.05 for between group (patient vs proxy) difference based on t-test at baseline, follow-up, or change in scores. ƚp < 0.05 for within group (patient or proxy) change between baseline and follow-up based on paired t-test. ǂHigher scores indicate worse symptoms/functioning; ICC = intra-class correlation coefficient with 95% confidence interval (CI) based on a two-way random effects model for single rater consistency. An ICC of < 0.40, 0.41–0.60, 0.61–0.80, and > 0.80 indicates poor, moderate, substantial, and high reliability, respectively